scispace - formally typeset
P

Pamela V. Chang

Researcher at Cornell University

Publications -  27
Citations -  4796

Pamela V. Chang is an academic researcher from Cornell University. The author has contributed to research in topics: Bioorthogonal chemistry & Microbiome. The author has an hindex of 15, co-authored 22 publications receiving 3927 citations. Previous affiliations of Pamela V. Chang include University of California, Berkeley & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

Copper-free click chemistry for dynamic in vivo imaging

TL;DR: A Cu-free variant of click chemistry that can label biomolecules rapidly and selectively in living systems, overcoming the intrinsic toxicity of the canonical Cu-catalyzed reaction is reported.
Journal ArticleDOI

The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition

TL;DR: It is demonstrated that the short-chain fatty acid n-butyrate, which is secreted in high amounts by commensal bacteria, can modulate the function of intestinal macrophages, the most abundant immune cell type in the lamina propria, and elucidate a pathway in which the host may maintain tolerance to intestinal microbiota by rendering lamina Propria macrophage hyporesponsive to commensals through the down-regulation of proinflammatory effectors.
Journal ArticleDOI

Copper-free click chemistry in living animals

TL;DR: Cu-free click chemistry is established as a bioorthogonal reaction that can be executed in the physiologically relevant context of a mouse for labeling biomolecules in live mice.
Journal ArticleDOI

Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor.

TL;DR: It is discovered that three gut microbially produced, small-molecule metabolites, which derive from dietary tryptophan, improve intestinal barrier integrity and protect against inflammation caused by IBDs.
Journal ArticleDOI

Metabolic labeling of sialic acids in living animals with alkynyl sugars.

TL;DR: N-(4-pentynoyl)mannosamine can be used to metabolically label sialylated glycoproteins in living animals, enabling future identification of new biomarkers.